Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Rangering i aksjer #35
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Aksjekurs
$419.17
Markedsverdi
$333.66B
Endring (1 dag)
0.50%
Endring (1 år)
21.90%
Land
CH
Handel Roche Holding AG (ROG)

Kategori

Antall utestående aksjer for Roche Holding AG (ROG)
Antall utestående aksjer per December 2025: 796.00M
Ifølge Roche Holding AG sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 796.00M. Ved slutten av December 2019 hadde selskapet 856.00M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Roche Holding AG (ROG) fra 2019 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 796.00M -6.35%
2021 850.00M -0.70%
2019 856.00M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land